ANNE ROWLAND: Open Payments
NPI 1689840571 · HAGERSTOWN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$691 in 44 payments from 12 companies in 2025. Trend: 2023 $480 · 2024 $592 · 2025 $691
Food & beverage: $691
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 17 | $179 |
| AstraZeneca Pharmaceuticals LP | 6 | $110 |
| Viatris Specialty LLC | 3 | $76 |
| Axsome Therapeutics, Inc. | 3 | $56 |
| GENZYME CORPORATION | 3 | $56 |
| United Therapeutics Corporation | 3 | $53 |
| Grifols USA, LLC | 2 | $43 |
| Baxter Healthcare | 1 | $37 |
| Electromed, Inc. | 3 | $29 |
| Novo Nordisk Inc | 1 | $19 |
Products named: AIRSUPRA, TRELEGY ELLIPTA, NUCALA, YUPELRI, Sunosi, DUPIXENT, Tyvaso, Prolastin-C Liquid.
Industry payments across MD — which companies pay providers there.
